Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment
JournalBMC Health Services Research
MetadataShow full item record
AbstractBackground: Medications for opioid use disorder (MOUD) are recommended with adjuvant behavioral therapies, counseling, and other services for comprehensive treatment of maternal opioid use disorder. Inadequate access to treatment, lack of prescribing providers and complex delivery models are among known barriers to care. Multi-disciplinary provider input can be leveraged to comprehend factors that facilitate or inhibit treatment. The objective of this study is to explore provider perceptions of MOUD and factors critical to comprehensive treatment delivery to improve the care of pregnant women with opioid use disorder. Methods: A qualitative research approach was used to gather data from individual provider and group semi-structured interviews. Providers (n = 12) responded to questions in several domains related to perceptions of MOUD, treatment delivery, access to resources, and challenges/barriers. Data were collected, transcribed, coded (by consensus) and emerging themes were analyzed using grounded theory methodology. Results: Emerging themes revealed persistent gaps in treatment and challenges in provider, health systems and patient factors. Providers perceived MOUD to be a "lifeline" to women. Conclusions: Inconsistencies in treatment provision, access and uptake can be improved by leveraging provider perceptions, direct experiences and recommendations for an integrated team-based, patient-centered approach to guide the care of pregnant women with opioid use disorder. Copyright 2021, The Author(s).
SponsorsThis study was supported by the Parent Project Grant #10020715, Patient-Centered Involvement in Evaluating the Effectiveness of Treatments (PATIENT) and Patient-Centered Outcomes Research (PCOR) projects.
KeywordMedications for opioid use disorder
Opioid use disorder
Pregnancy and healthcare provider
Qualitative pilot study
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15169
- Provider perceptions of medication for opioid used disorder (MOUD): A qualitative study in communities with high opioid overdose death rates.
- Authors: Paul N, Kennedy AJ, Taubenberger S, Chang JC, Hacker K
- Issue date: 2022
- Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers.
- Authors: King Z, Kramer C, Latkin C, Sufrin C
- Issue date: 2021 Jul
- "You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.
- Authors: Schiff DM, Work EC, Muftu S, Partridge S, MacMillan KDL, Gray JR, Hoeppner BB, Kelly JF, Greenfield SF, Jones HE, Wilens TE, Terplan M, Bernstein J
- Issue date: 2022 Mar 18
- Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention.
- Authors: Gustavson AM, Kenny ME, Wisdom JP, Salameh HA, Ackland PE, Gordon AJ, Hagedorn HJ
- Issue date: 2021 Aug 6
- Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities.
- Authors: Hawkins EJ, Danner AN, Malte CA, Blanchard BE, Williams EC, Hagedorn HJ, Gordon AJ, Drexler K, Burden JL, Knoeppel J, Lott A, Sayre GG, Midboe AM, Saxon AJ
- Issue date: 2021 Sep 6